RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies GlobeNewswire October 27, 2025 Trial initiation in food allergy follows promising results in Phase 2 trial in chronic spontaneous urticaria, another IgE-driven condition RAPT seeks to develop a differentiated anti-IgE therapy for the many patients with food allergies SOUTH […]

(NASDAQ:EVAX), Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record of strategic partnership deals Her more than 30 years of experience include leadership roles in the UK and US, from early research through to product approval in cancer immunotherapy, making her the ideal candidate

Jefferson Capital to Acquire Credit Card Portfolio with Face Value of $488 Million GlobeNewswire October 27, 2025 MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) — Jefferson Capital, Inc. (NASDAQ: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off and insolvency consumer accounts, announced today that a wholly owned subsidiary has entered into a

(LSE:OXB), OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that members of its senior management team, including Dr. Frank Mathias, Chief Executive Officer, and Dr. Lucy Crabtree, Chief Financial Officer, will participate in

Marex Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MRX GlobeNewswire October 27, 2025 LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Marex Group plc (“Marex” or “the Company”) (NASDAQ: MRX) for violations

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform Live Technical Demonstration Validates NeuroSense AI Platform Feasibility; Development Moves Forward with Proven Core Technologies GlobeNewswire October 27, 2025 JACKSON CENTER, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) — Halberd Corporation (OTC: HALB) today announced the successful completion of a technical feasibility demonstration

Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer GlobeNewswire October 27, 2025 SOLANA BEACH, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, today

Navient Named Champion of Board Diversity by The Forum of Executive Women GlobeNewswire October 27, 2025 HERNDON, Va., Oct. 27, 2025 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) today announced its designation as a Champion of Board Diversity by The Forum of Executive Women, the Greater Philadelphia Region's premier women's professional organization. The Forum of Executive

Southern Realty Trust Commits $15.0 Million to a $45.0 Million Senior Bridge Loan for the Refinancing of a Premier Retail Property in Houston, TX GlobeNewswire October 27, 2025 WEST PALM BEACH, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Southern Realty Trust Inc. (“SRT” or the “Company”), a lender on the Tannenbaum Capital Group (“TCG”) Real

Sunrise Realty Trust Commits $30.0 Million to a $45.0 Million Senior Bridge Loan to Refinance a Premier Retail Property in Houston, TX GlobeNewswire October 27, 2025 WEST PALM BEACH, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real